We evaluate CHANDO Group's 2026 research on scalp microbiome modulation. Learn what this preliminary cosmetic science means for evidence-based hair loss care.
In October 2026, CHANDO Group announced new cosmetic research regarding scalp care and hair retention. The company presented a poster titled "Construction of a scalp microecological balance-oriented anti-hair loss system" at the 36th Congress of the International Federation of Societies of Cosmetic Chemists (IFSCC). This major industry event took place in Perth, Australia, from September 28 to October 1, 2026. The October 6 public announcement outlines a strategy focused on targeted adjustments to the bacterial environment of the scalp.
The skin on our heads is home to a complex community of microscopic organisms. These bacteria and fungi must coexist peacefully to support healthy, functioning hair follicles over time. CHANDO Group describes its newly proposed concept as the targeted modulation of the scalp microbiome. This specialized approach aims to maintain microbial balance and support efficacy against hair shedding. By keeping the environment stable, the theory suggests that follicles can function optimally without inflammatory disruptions.
This proposed strategy significantly differs from conventional dermatological methods that rely on broad-spectrum antimicrobial activity. Broad-spectrum treatments typically eliminate both beneficial and harmful bacteria at the same time. While effective for certain conditions, this aggressive clearance can sometimes disrupt the natural protective barrier of the skin. CHANDO Group notes that their new research also moves away from relying on a single probiotic ingredient for routine scalp care.
Instead of wiping out all bacteria or introducing just one beneficial strain, the theoretical goal is targeted management. The focus is to selectively encourage beneficial microorganisms while keeping disruptive microbial strains securely in check. By focusing on targeted modulation, scientists hope to create a more resilient scalp environment. In theory, this balanced ecosystem naturally supports the biological hair growth cycle without unnecessary chemical interference.
The research presentation at the IFSCC congress highlights a significant institutional focus on cosmetic science. CHANDO Group proudly reported that 20 of its research papers were accepted for the prestigious 2026 congress. The company stated this impressive volume placed it among the top five organizations worldwide by accepted-paper count. These metrics suggest a highly active research and development department within the organization.
Furthermore, the company highlighted a long history of participation in this specific global scientific forum. CHANDO Group reported active participation for 12 consecutive years at the IFSCC. In addition, the organization noted a total of 79 accepted papers since 2015. While these figures demonstrate a sustained research output, they do not reflect clinical success rates for the scalp microbiome treatment itself.
The public release distributed by Yonhap and PRNewswire focuses entirely on the volume of accepted papers. It does not provide any measurable biological outcomes for the actual hair retention concepts being discussed. Evaluating beauty longevity claims requires a clear distinction between corporate research volume and proven clinical efficacy. A high number of scientific posters does not automatically equal a successful topical treatment.
It is absolutely critical to distinguish early scientific proposals from proven clinical interventions. The October 6 public announcement provides no methods, formulation details, or targeted microbial taxa for poster 1067. Furthermore, it provides no sample size, study duration, or numerical results. The absence of this foundational data makes it impossible to evaluate the true potential of the proposed system.
Crucially, there are zero human clinical outcomes reported to verify that this microbiome strategy prevents hair loss in real-world patients. The provided text contains no named executive or researcher quotation to offer additional scientific context. Without published clinical trials, consumers cannot know if the treatment is safe or effective. We also do not know which specific forms of shedding this conceptual product might eventually address.
Additionally, the distributed press release features formatting inconsistencies that advise necessary caution. The document footnotes appear to contain a citation mismatch regarding the specific research being highlighted. The paragraph discussing the scalp-microbiome approach points to footnote 4, while the listed scalp-balance poster is actually footnote 2. Readers should wait for published methods and safety information before considering this a viable alternative to established care.
Health-conscious women should treat microbiome modulation as an interesting future direction rather than an immediate solution. You should never replace or delay the evaluation of ongoing hair thinning based on preliminary conference posters. The American Academy of Dermatology firmly advises that effective treatment begins with identifying the specific underlying cause of the shedding. Because thinning can stem from genetics or systemic changes, professional evaluation remains crucial.
The organization highly recommends seeing a dermatologist for a proper, evidence-based diagnosis. Women who want to understand the clinical evaluation process can review our comprehensive guide on how hair loss is diagnosed to prepare for their medical appointment. For those seeking established medical options, the American Academy of Dermatology lists minoxidil as a primary option for female-pattern hair loss. According to their medical guidance, minoxidil may stimulate hair growth and help prevent further loss when used as directed.
Patience is essential when evaluating the success of any topical intervention for your scalp. The organization specifically notes that it can take about 6 to 12 months to properly assess results from minoxidil treatments. Understanding this extended biological timeline helps manage expectations and significantly reduces daily frustration. Readers deciding on a long-term plan should carefully weigh the available evidence.
You can gain context by consulting our resources on how female hair loss treatments compared stack up against one another in clinical settings. It is easy to be swayed by exciting new terminology like microecological balance or microbiome modulation. However, long-term consistency with proven methods remains the most effective strategy for healthy aging. Building a solid understanding of female pattern hair loss causes will serve you far better than chasing unproven trends.
Mapping the microscopic ecosystem of the scalp represents a fascinating, evolving frontier in biological research. As cosmetic chemists continue to study the diverse microorganisms living on our skin, targeted topical treatments may eventually become standard practice. Will future clinical trials finally provide the necessary safety and efficacy data to bring microbiome modulation into our daily routines? Until those rigorous human studies are published, the wisest approach remains grounded in established dermatological care, accurate diagnosis, and consistent treatment timelines.
Stay connected for research and practical guidance on skin, hair, collagen, nutrition and beauty longevity. Clear ideas for people who want to understand how appearance changes with age and make better-informed choices over time.
Understand your skin, hair and body better without chasing every new trend, treatment or promise.
explore the Blog
